From antimedia.com (no longer existing) 2018
via greenmedinfo.com

By Carey Wedler
One of the most reviled companies in the United States recently gave Americans yet another reason to distrust their power: A recent Goldman Sachs report reveals the company questioning whether or not curing chronic illness is compatible with a sustainable business model.

In an internal report viewed by CNBC about the potential of the biotech industry and gene therapy titled “The Genome Revolution,” analysts asked: “Is curing patients a sustainable business model?”

READ AT THE LINK

Editor comment: do you still think that big pharma is interested in actually curing you? You’re their cash cow. Managing symptoms is way more profitable. EWNZ